ACRO Biomedical Co Stock

ACRO Biomedical Co OCF Margin

The Operating Cash Flow Margin of ACRO Biomedical Co (6748.TWO) as of Jul 27, 2026 is -128.11 %. In the previous year, Operating Cash Flow Margin was -98.06 % — a change of 30.65% (lower).

OCF Margin

-128.11 %

YoY

30.65%

Last updated:

Operating Cash Flow Margin of ACRO Biomedical Co is 2026 -128.11 % . Operating Cash Flow Margin of ACRO Biomedical Co was 2025 -98.06 % . It decreases by 30.65% lower compared to the previous year.
Access this data via the Eulerpool API

ACRO Biomedical Co Stock analysis

What does ACRO Biomedical Co do? ACRO Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ACRO Biomedical Co stock

Operating Cash Flow Margin of ACRO Biomedical Co is -128.11 % in 2026.

Access this data via the Eulerpool API

Margins — ACRO Biomedical Co

All Key Metrics — ACRO Biomedical Co